tiprankstipranks
Eisai Co (ESALY)
OTHER OTC:ESALY

Eisai Co (ESALY) Stock News & Sentiment

0 Followers
Eisai, Biogen say lecanemab received Priority Review status in Japan
PremiumThe Fly
Eisai, Biogen say lecanemab received Priority Review status in Japan
1y ago
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
PremiumThe Fly
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
1y ago
Catalyst Pharmaceuticals completes acquisition of U.S. rights to FYCOMPA CII
PremiumThe Fly
Catalyst Pharmaceuticals completes acquisition of U.S. rights to FYCOMPA CII
1y ago
Donanemab CRL a ‘positive headline’ for Biogen’s Leqembi, says William Blair
PremiumThe Fly
Donanemab CRL a ‘positive headline’ for Biogen’s Leqembi, says William Blair
1y ago
Eisai submits marketing authorization application for lecanemab in Japan
PremiumThe Fly
Eisai submits marketing authorization application for lecanemab in Japan
1y ago
Eisai submits MAA for lecanemab to EMA
PremiumThe Fly
Eisai submits MAA for lecanemab to EMA
1y ago
Eisai submits Leqembi sBLA to FDA
PremiumThe Fly
Eisai submits Leqembi sBLA to FDA
1y ago
More ESALY News >

News Score - Last 7 Days

Neutral
ESALY
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESALY’s Media Buzz Sentiment?
Currently, no data Available
What is ESALY’s weekly average amount of articles?
Currently, no data Available
What is ESALY’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
HOOKHookipa Pharma
PRVBProvention Bio
BLCMBellicum Pharmaceuticals
VSTMVerastem
ARDSAridis Pharmaceuticals
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis